Peak Pharmaceuticals, Inc. operates as a biopharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THCfree, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.
General Outlook
In simple terms, Peak Pharmaceuticals, Inc. has 0.392 M shares that people are buying and selling right now.
Stock Prices
Peak Pharmaceuticals, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $3.5, while its low point bottomed out at $3.5. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Peak Pharmaceuticals, Inc.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”